Pablo Pereira Ghimenti

CV Lattes

Faculdade São Leopoldo Mandic (SLMANDIC). Centro de Pesquisas Odontológicas São Leopoldo Mandic (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Pablo Pereira Ghimenti in research grants and scholarships supported by FAPESP.

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Completed (most recent)

Abstract
Oral squamous cell carcinoma (OSCC) is the 6th commonest malignant neoplasm in Brazil. Current treatment includes surgery and/or radiotherapy. Overall 5-year survival is 50%. 15d-PGJ2 is a prostaglandin (PG) of the J2 series, which differs from other PG by an electrophilic carbonyl group on the cyclepentenone ring. This confers this molecule its anti-inflammatory and anti-tumour properti…
Effect of 15d-PGJ2 on proliferation, viability and oxidative stress of an oral squamous cell carcinoma cell line in vitro, BP.IC

Virtual Library in numbers * Updated data on August 23, 2025

Total / Available in English

1 / 1	Completed scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

Marcelo Sperandio

Keywords used by the researcher

Dentistry Health Sciences

Please report errors on the page using this form.

Short URL

Abstract